Business Wire

WhereScape Announces Cloud Data Warehouse Automation for Snowflake

7.8.2017 16:00:00 EEST | Business Wire | Press release

Share

WhereScape, the leading provider of data infrastructure automation software, today announced WhereScape® automation for Snowflake, an offering designed to help IT organizations speed up the delivery of cloud-based data infrastructure projects. WhereScape will showcase the new offering this week during the TDWI Conference in Anaheim, Calif.

WhereScape automation for Snowflake automates key development and operations workflows for Snowflake customers based on the native functions, wizards and best practices of Snowflake and incorporates data warehouse modelling methodologies such as 3NF, dimensional and Data Vault 2.0. Snowflake provides cloud-based data warehousing solutions that deliver the performance, elasticity, scalability, concurrency and simplicity needed to store and analyze all of an organization’s data in one location.

“The combination of WhereScape’s data warehouse automation tools with Snowflake's zero administration service is perfect for enabling our customers to be successful with agile data warehousing,” said Kent Granziano, senior technical evangelist of Snowflake. “WhereScape automation for Snowflake makes it possible for organizations to start using Snowflake faster and more easily by simplifying and automating the design, build and population of data warehouse tables. Our customers will benefit from the effortless, simple, drag and drop interface, with which they can point at a source database, or even flat files, then load that data right into Snowflake with zero coding! That is agile.”

“Our health and life sciences clients rely on us to execute flawless marketing campaigns and deliver customer insights from across our many digital platforms,” said Peter Nilsson, Chief Technology Officer of Aptus Health. “To that end, we’re leveraging WhereScape’s ability to ease our design and implementation effort as we develop our fully-integrated warehouse on Snowflake. WhereScape's tools will save us thousands of engineering hours, promote implementation accuracy, and accelerate our time to delivery. And since WhereScape natively supports Snowflake, we can use the generated code without having to tailor it to our target environment—letting us focus on generating the insights that will drive our business forward.”

WhereScape automation for Snowflake includes:

  • WhereScape® 3D for Snowflake helping IT teams quickly and effectively tackle the upfront planning, modelling and design needed to rapidly put Snowflake to use. WhereScape 3D data discovery and profiling tools allow customers to more easily understand new data sources and leverage automation built for Snowflake to quickly build, test and iterate on prototypes with business users.
  • WhereScape® RED for Snowflake, an integrated development environment, providing IT teams the ability to develop, deploy and operate Snowflake data infrastructure faster. With built-in automation based on native Snowflake functions, wizards and best practices, customers can eliminate the time-intensive hand-coding involved in data infrastructure development. Advanced DevOps capabilities allow users to quickly establish new environments, continuously migrate changes and operate data processing in Snowflake – all with best practices automatically utilized. WhereScape RED for Snowflake automatically generates and maintains user and technical documentation such as data lineage, track back, and track forward for future reference, lifting a time-intensive burden off IT teams.
  • WhereScape® Data Vault Express™ for Snowflake, an integrated combination of WhereScape 3D and WhereScape RED embedded with Data Vault 2.0 specific capabilities, empowering teams to more practically deliver data vaults.

"Whether large or small, organizations today are grappling with the strategy, tactics and timing of moving on-premises data into the cloud," said Matt Aslett, Research Director of 451 Research. "Automating data movement and populating data warehouse tables in the cloud promises to smooth the transition path for IT teams, providing more time to focus on the business value of the transition and associated analytics applications.”

“IT faces enormous pressure to deliver decision-support information faster than ever before,” said Mark Budzinski, CEO of WhereScape. “As the growth of data doubles nearly every other year, organizations are increasingly feeling squeezed for resources and time. Many look to the cloud to address these challenges. We are excited to help Snowflake customers maximize their adoption of a cloud strategy and fast-track their use of Snowflake by addressing head-on the thrash and hidden costs of designing, developing, deploying and operating data infrastructure.”

Mark Budzinski, CEO of WhereScape, and Jon Bock, VP of product and partner marketing for Snowflake Computing, will discuss the offering together today on the #InsideAnalysis radio podcast at 3PM ET, with a follow-up Deep Dive Webcast at 4PM ET. Additionally, WhereScape’s Jason Laws, vice president of product management, will present today at the TDWI Leadership Summit at 2:15PM PT.

Learn more about WhereScape automation for Snowflake here
WhereScape #InsideAnalysis podcast and Deep Dive webcast here

About WhereScape

WhereScape helps IT organizations of all sizes leverage automation to design, develop, deploy, and operate data infrastructure faster. More than 700 customers worldwide rely on WhereScape automation to eliminate hand-coding and other repetitive, time-intensive aspects of data infrastructure projects to deliver data warehouses, vaults, lakes and marts in days or weeks rather than in months or years. WhereScape has offices in Portland, Oregon; Reading, UK; Auckland, New Zealand; and Singapore. For more information, please visit www.wherescape.com

All products or company names herein may be trademarks of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

WhereScape
Ruth Armitage/Sarah Shkargi
wherescape@touchdownpr.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 11:00:00 EEST | Press release

OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 18:15:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 13:00:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202613.6.2026 00:31:00 EEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 19:36:00 EEST | Press release

IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye